Cancer Experiences Collaborative (CECo) Logo - Click here to return to the home page
 
Innovative Approaches to Complex Symptoms
Methodology
Older Adults and Supportive and Palliative Care
Research Partners
Research Capacity
On-line Exchange
Other months:
Information about CECo CECo General Calendar Document resources Other CECo Services
About CECo
CECo Collaborators
Member Profiles
CECo Events
Next event:

19th October 2010
2nd National End of Life Care Conference
(External event)
Document resources
Links of interest
Contact us
CECo Funding
CECo Publications
CECo News <<<<<< For CECo-wide news, click the button to the left ... CECO Older People theme Funding opportunity, Invitation to Nominate - 2011-12 U.K. Harkness Fellowships in Health Care Policy and Practice (IV),
An introduction to CECo

Effectiveness of a Home Care Nursing Program in the Symptom Management of Patients With Colorectal and Breast Cancer Receiving Oral Chemotherapy: A Randomized, Controlled Trial

Alex Molassiotis, Sarah Brearley, Mark Saunders, Olive Craven, Andrew Wardley, Carole Farrell, Ric Swindell, Chris Todd, and Karen Luker
Journal of Clinical Oncology
(December 2009)

Link to ArticlePurpose: To assess the effectiveness of a symptom-focused home care program in patients with cancer who were receiving oral chemotherapy in relation to toxicity levels, anxiety, depression, quality of life, and service utilization.

Patients and Methods: A randomized, controlled trial was carried out with 164 patients with a diagnosis of colorectal (n = 110) and breast (n = 54) cancers who were receiving oral capecitabine. Patients were randomly assigned to receive either a home care program by a nurse or standard care for 18 weeks (ie, six cycles of chemotherapy). Toxicity assessments were carried out weekly for the duration of the patients' participation in the trial, and validated self-report tools assessed anxiety, depression, and quality of life.

Results: Significant improvements were observed in the home care group in relation to the symptoms of oral mucositis, diarrhea, constipation, nausea, pain, fatigue (first four cycles), and insomnia (all P < .05). This improvement was most significant during the initial two cycles. Unplanned service utilization, particularly the number of inpatient days (57 v 167 days; P = .02), also was lower in the home care group.

Conclusion: A symptom-focused home care program was able to assist patients to manage their treatment adverse effects more effectively than standard care. It is imperative that patients receiving oral chemotherapy are supported with such programs, particularly during initial treatment cycles, to improve their treatment and symptom experiences.

URL to article:
http://jco.ascopubs.org/cgi/content/abstract/JCO.2008.20.6755v1


  Back to top